Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins

International Journal of Cancer

Volumn 109, Issue 2, 2004, Pages 189-193

  Hedberg, Ylva ^a   Ljungberg, Börje ^a   Roos, Göran ^a   Landberg, Göran ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Cell cycle; G1 S cyclins; Phosphorylation; Renal cell carcinoma; Retinoblastoma protein

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYCLINE; DNA; PROTEIN P16; PROTEIN P27; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DNA, NEOPLASM; FEMALE; G1 PHASE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PHOSPHORYLATION; PLOIDIES; RETINOBLASTOMA PROTEIN; S PHASE; TUMOR SUPPRESSOR PROTEINS;

EID: 1242342071     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11665     Document Type: Article

References (28)

1. Connell-Crowley L, Elledge SJ, Harper JW. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr Biol 1998;8:65-8.
2. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000;60:3689-95.
3. Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G, Barnes D. Cyclin D1 and prognosis in human breast cancer. Int J Cancer 1996;69:92-9.
4. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, Beger HG. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 1997;57: 1634-7.
5. Palmqvist R, Stenling R, Öberg Å, Landberg G. Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer 1998;34:1575-81.
6. Hedberg Y, Davoodi E, Roos G, Ljungberg B, Landberg G. Cyclin D1 expression in renal cell carcinoma. Int J Cancer 1999;84:268-72.
7. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54:1812-7.
8. Åkervall JA, Michalides RJ, Mineta H, Balm Å, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997;79:380-9.
9. Russell A, Thompson MA, Hendley J, Trute L, Armes J, Germain D. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 1999;18:1983-91.
10. Lin BT, Brynes RK, Gelb AB, McCourty A, Amin MB, Medeiros LJ. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study. Mod Pathol 1998;11:1075-81.
11. Lukas J, Aagaard L, Strauss M, Bartek J. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res 1995;55:4818-23.
12. Ishikawa J, Xu HJ, Hu SX, Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 1991;51:573-643.
13. Presti JC Jr, Reuter VE, Cordon-Cardo C, Motzer RJ, Albino AP, Jhanwar SC, Nanus DM. Expression of the retinoblastoma gene product in renal tumours. Anticancer Res 1996;16:549-56.
14. Sobin LH, Wittekind CH, eds. TNM classification of malignant tumours, 5th ed. New York: Wiley-Liss, 1997. 180-2.
15. Skinner DG, Colvin RB, Vermillon CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma: a clinical and pathological study of 309 cases. Cancer 1971;28:1165-77.
16. Hedberg Y, Ljungberg B, Roos G, Landberg G. Expression of cyclin D1, D3, E and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 2003;88:1418-24.
17. Ljungberg B, Mehle C, Stenling R, Roos G. Heterogeneity in renal cell carcinoma and its impact on prognosis: a flow cytometric study. Br J Cancer 1996;74:123-7.
18. Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 2000;14:2393-409.
19. Bartkova J, Lukas J, Bartek J. Aberrations of the G1- and G1/ S-regulating genes in human cancer. Prog Cell Cycle Res 1997;3:211-20.
20. Lai S, Benedict WF, Silver SA, El-Naggar AK. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. Hum Pathol 1997;28:693-7
21. Nielsen NH, Emdin SO, Cajander J, Landberg G. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 1997;14:295-304.
22. Hedberg Y, Roos G, Ljungberg B, Landberg G. Cyclin D3 Protein Content in Human Renal Cell Carcinoma in Relation to Cyclin D1 and Clinico-pathological Parameters. Acta Oncol 2002;41:175-81.
23. Hedberg Y, Davoodi E, Ljunberg B, Roos G, Landberg G. Aberrant cyclin E and p27 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D. Int J Cancer 2002; 102:601-7.
24. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjanen K, Kosma VM. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer 1999;80:2001-7.
25. Migita T, Oda Y, Naito S, Tsuneyoshi M. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 2002;94:973-9.
26. Haitel A, Wiener HG, Neudert B, Marberger M, Susani M. Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urology 2001;58:477-81.
27. Sommi P, Savio M, Stivala LA, Scotti C, Mignosi P, Prosperi E, Vannini V, Solcia E. Helicobacter pylori releases a factor(s) inhibiting cell cycle progression of human gastric cell lines by affecting cyclin E/cdk2 kinase activity and Rb protein phosphorylation through enhanced p27(KIP1) protein expression. Exp Cell Res 2002;281:128-39.
28. Brantley MA Jr, Harbour JW. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region. Cancer Res 2000;60:4320-3.